Clinical Trials Logo

Manic State clinical trials

View clinical trials related to Manic State.

Filter by:
  • None
  • Page 1

NCT ID: NCT00521365 Completed - Bipolar Disorder Clinical Trials

Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.

EMMY
Start date: May 2008
Phase: Phase 4
Study type: Interventional

The primary purpose of the study is to assess the efficacy of Quetiapine extended release 600mg per day either as monotherapy or combined therapy in the treatment of patients with mania associated to Bipolar disorder. This trial will also assess the life quality and productivity loss improvement for patients from baseline to day 21.

NCT ID: NCT00431184 Completed - Bipolar Disorder Clinical Trials

Effects of Pentazocine Versus Lorazepam on Manic Symptoms

Start date: January 2007
Phase: Phase 2
Study type: Interventional

Pilot data indicates that pentazocine decreases manic symptoms in hospitalized individuals. To follow up these initial findings, we plan to conduct a larger, more rigorous, double-blind study. We will examine whether pentazocine, an agent with kappa-opiate activity, decreases manic symptoms.

NCT ID: NCT00422123 Completed - Mania Clinical Trials

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

Start date: January 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Mania for 3 weeks. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.